Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from

P A Mehta1, S M Davies, A Kumar

  • 1Division of Hematology Oncology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229, USA. parinda.mehta@ccmhc.org

Leukemia
|June 23, 2006
PubMed

Insights

The perforin A91V gene variant does not increase childhood acute lymphoblastic leukemia (ALL) risk overall. However, it was found more frequently in children with BCR-ABL positive ALL, warranting further investigation.

Area of Science:

  • Immunology
  • Genetics
  • Oncology

Background:

  • Perforin is crucial for natural killer and cytotoxic T cell function.
  • PRF1 gene mutations cause familial hemophagocytic lymphohistiocytosis.
  • The PRF1 A91V polymorphism may affect perforin processing and has been linked to childhood acute lymphoblastic leukemia (ALL) susceptibility.

Purpose of the Study:

  • To investigate the association between the PRF1 A91V polymorphism and childhood de novo acute lymphoblastic leukemia (ALL).

Main Methods:

  • Genotyping of 2272 children with de novo ALL and 655 normal controls.
  • Analysis restricted to white cases and controls due to population-specific allele frequencies.
  • Comparison of genotype frequencies between ALL cases and controls.

Main Results:

  • No significant association was found between the PRF1 A91V polymorphism and overall childhood ALL risk in white populations (P=0.58).
  • The PRF1 A91V allele frequency was significantly higher in children with BCR-ABL positive ALL compared to controls (24% vs 8.5%, P=0.0048).

Conclusions:

  • The PRF1 A91V polymorphism is not associated with an increased risk of childhood ALL.
  • A potential association between PRF1 A91V and BCR-ABL positive ALL requires further research due to the small sample size.